Efficacy and potential determinants of exercise therapy in knee and hip osteoarthritis: A systematic review and meta-analysis.


Journal

Annals of physical and rehabilitation medicine
ISSN: 1877-0665
Titre abrégé: Ann Phys Rehabil Med
Pays: Netherlands
ID NLM: 101502773

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 13 11 2018
revised: 04 04 2019
accepted: 10 04 2019
pubmed: 24 5 2019
medline: 4 3 2020
entrez: 24 5 2019
Statut: ppublish

Résumé

Exercise is an effective treatment for osteoarthritis. However, the effect may vary from one patient (or study) to another. To evaluate the efficacy of exercise and its potential determinants for pain, function, performance, and quality of life (QoL) in knee and hip osteoarthritis (OA). We searched 9 electronic databases (AMED, CENTRAL, CINAHL, EMBASE, MEDLINE Ovid, PEDro, PubMed, SPORTDiscus and Google Scholar) for reports of randomised controlled trials (RCTs) comparing exercise-only interventions with usual care. The search was performed from inception up to December 2017 with no language restriction. The effect size (ES), with its 95% confidence interval (CI), was calculated on the basis of between-group standardised mean differences. The primary endpoint was at or nearest to 8 weeks. Other outcome time points were grouped into intervals, from<1 month to≥18 months, for time-dependent effects analysis. Potential determinants were explored by subgroup analyses. Level of significance was set at P≤0.10. Data from 77 RCTs (6472 participants) confirmed statistically significant exercise benefits for pain (ES 0.56, 95% CI 0.44-0.68), function (0.50, 0.38-0.63), performance (0.46, 0.35-0.57), and QoL (0.21, 0.11-0.31) at or nearest to 8 weeks. Across all outcomes, the effects appeared to peak around 2 months and then gradually decreased and became no better than usual care after 9 months. Better pain relief was reported by trials investigating participants who were younger (mean age<60 years), had knee OA, and were not awaiting joint replacement surgery. Exercise significantly reduces pain and improves function, performance and QoL in people with knee and hip OA as compared with usual care at 8 weeks. The effects are maximal around 2 months and thereafter slowly diminish, being no better than usual care at 9 to 18 months. Participants with younger age, knee OA and not awaiting joint replacement may benefit more from exercise therapy. These potential determinants, identified by study-level analyses, may have implied ecological bias and need to be confirmed with individual patient data.

Sections du résumé

BACKGROUND BACKGROUND
Exercise is an effective treatment for osteoarthritis. However, the effect may vary from one patient (or study) to another.
OBJECTIVE OBJECTIVE
To evaluate the efficacy of exercise and its potential determinants for pain, function, performance, and quality of life (QoL) in knee and hip osteoarthritis (OA).
METHODS METHODS
We searched 9 electronic databases (AMED, CENTRAL, CINAHL, EMBASE, MEDLINE Ovid, PEDro, PubMed, SPORTDiscus and Google Scholar) for reports of randomised controlled trials (RCTs) comparing exercise-only interventions with usual care. The search was performed from inception up to December 2017 with no language restriction. The effect size (ES), with its 95% confidence interval (CI), was calculated on the basis of between-group standardised mean differences. The primary endpoint was at or nearest to 8 weeks. Other outcome time points were grouped into intervals, from<1 month to≥18 months, for time-dependent effects analysis. Potential determinants were explored by subgroup analyses. Level of significance was set at P≤0.10.
RESULTS RESULTS
Data from 77 RCTs (6472 participants) confirmed statistically significant exercise benefits for pain (ES 0.56, 95% CI 0.44-0.68), function (0.50, 0.38-0.63), performance (0.46, 0.35-0.57), and QoL (0.21, 0.11-0.31) at or nearest to 8 weeks. Across all outcomes, the effects appeared to peak around 2 months and then gradually decreased and became no better than usual care after 9 months. Better pain relief was reported by trials investigating participants who were younger (mean age<60 years), had knee OA, and were not awaiting joint replacement surgery.
CONCLUSIONS CONCLUSIONS
Exercise significantly reduces pain and improves function, performance and QoL in people with knee and hip OA as compared with usual care at 8 weeks. The effects are maximal around 2 months and thereafter slowly diminish, being no better than usual care at 9 to 18 months. Participants with younger age, knee OA and not awaiting joint replacement may benefit more from exercise therapy. These potential determinants, identified by study-level analyses, may have implied ecological bias and need to be confirmed with individual patient data.

Identifiants

pubmed: 31121333
pii: S1877-0657(19)30062-4
doi: 10.1016/j.rehab.2019.04.006
pmc: PMC6880792
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

356-365

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Masson SAS. All rights reserved.

Références

Curr Aging Sci. 2012 Feb;5(1):72-83
pubmed: 21762086
Rheumatol Int. 2012 Nov;32(11):3339-51
pubmed: 22821333
Phys Ther. 2014 Oct;94(10):1383-95
pubmed: 24903110
Osteoarthritis Cartilage. 2010 May;18(5):613-20
pubmed: 20188228
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
Syst Rev. 2016 Sep 02;5(1):147
pubmed: 27590834
Cochrane Database Syst Rev. 2015 Oct 29;(10):CD010203
pubmed: 26513223
Osteoarthritis Cartilage. 2011 Nov;19(11):1270-85
pubmed: 21907813
J Bone Joint Surg Am. 2001 Nov;83(11):1622-9
pubmed: 11701783
Arthritis Rheumatol. 2014 Mar;66(3):622-36
pubmed: 24574223
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
Syst Rev. 2013 Jul 05;2:54
pubmed: 23830482
Cochrane Database Syst Rev. 2015 Jan 09;1:CD004376
pubmed: 25569281
Osteoarthritis Cartilage. 2012 Dec;20(12):1548-62
pubmed: 22944525
J Orthop Sports Phys Ther. 2018 Dec;48(12):943-950
pubmed: 30053792
Int J Evid Based Healthc. 2015 Mar;13(1):9-18
pubmed: 25734864
Br J Sports Med. 2014 Nov;48(21):1579
pubmed: 25313133
Stat Med. 2001 Dec 15;20(23):3625-33
pubmed: 11746342
Physiother Theory Pract. 2011 May;27(4):253-62
pubmed: 20649479
J Epidemiol Community Health. 2015 Feb;69(2):189-95
pubmed: 25481532
BMJ. 2010 Jul 16;341:c3515
pubmed: 20639294
Stat Med. 2002 Sep 30;21(18):2641-52
pubmed: 12228882
Semin Arthritis Rheum. 2014 Jun;43(6):701-12
pubmed: 24387819
J Bone Joint Surg Br. 2010 Jan;92(1):130-5
pubmed: 20044691
Clin Rehabil. 2016 Oct;30(10):947-959
pubmed: 26471972
Osteoarthritis Cartilage. 2015 Oct;23(10):1654-63
pubmed: 26050868
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
J Sci Med Sport. 2011 Jan;14(1):4-9
pubmed: 20851051
J Bone Joint Surg Am. 2004 Sep;86(9):1909-16
pubmed: 15342752
BMJ. 2001 Jun 2;322(7298):1357-60
pubmed: 11387189
Free Radic Biol Med. 2016 Jul;96:130-8
pubmed: 27109910
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
Heart Fail Clin. 2012 Jan;8(1):143-64
pubmed: 22108734
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Siew-Li Goh (SL)

Arthritis Research UK Pain Centre, Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, NG5 1PB Nottingham, UK; Sports Medicine Unit, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Monica S M Persson (MSM)

Arthritis Research UK Pain Centre, Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, NG5 1PB Nottingham, UK.

Joanne Stocks (J)

Arthritis Research UK Pain Centre, Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, NG5 1PB Nottingham, UK.

Yunfei Hou (Y)

Arthritis Clinical and Research Centre, Peking University People's Hospital, Beijing, China.

Jianhao Lin (J)

Arthritis Clinical and Research Centre, Peking University People's Hospital, Beijing, China.

Michelle C Hall (MC)

Division of Physiotherapy Rehabilitation Sciences Education, University of Nottingham, NG5 1PB Nottingham, UK.

Michael Doherty (M)

Arthritis Research UK Pain Centre, Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, NG5 1PB Nottingham, UK.

Weiya Zhang (W)

Arthritis Research UK Pain Centre, Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, NG5 1PB Nottingham, UK. Electronic address: weiya.zhang@nottingham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH